The implication of this proof - of - concept study of a novel technology for reversing transporter - related drug resistance, they say, «is not limited to
a single nanobody used to demonstrate the technology, nor to a single drug, nor indeed to trypanosomiasis.»
Not exact matches
About 20 years ago, it was discovered that the unique immune systems of camelids (llamas, camels, and alpacas) produce a pared down version of antibodies, featuring a
single binding domain called a
nanobody.
«
Nanobodies: natural
single - domain antibodies.»
A
nanobody is a ~ 150 amino acid,
single domain antibody.
Unlike most antibodies,
nanobodies, which occur naturally in camels, consist of a
single heavy chain, and they are small and stable inside cells.
As
single domain proteins, they can be expressed in bacteria, making
nanobodies a recombinant and renewable anti-IgG reagent.